BVS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BVS shares is 186, representing 69.88% of the company's common stock.

RENAISSANCE TECHNOLOGIES LLC, in the last quarter, reduced its stake in BVS by -25.81% restricting it's holding to 100.33 thousand shares of worth nearly $522.00K. NORTHERN TRUST CORP also lessened -11.24% of the BVS shares from its portfolio, reducing its holding to 79.07 thousand shares of worth $411.14K. BALYASNY ASSET MANAGEMENT L.P. also shunned BVS shares holding by -38.22% last quarter which brought its holding to 53.7 thousand shares worth $279.22K.

As per its latest 13F filing, JPMORGAN CHASE & CO increased its stake in BVS by 87.48% in the last quarter. The institutional holder raised its holding to 106.51 thousand shares having worth more than $553.83K. TWO SIGMA INVESTMENTS, LP also added 24.39% more shares of BVS to its portfolio, raising its holding to 105.68 thousand shares of worth $549.54K. HRT FINANCIAL LP also increased its BVS shares holding by 100% which brought its holding to 77.81 thousand shares worth $404.00K.

The insider with the most stakes in BVS is Bartholdson John A. , at the company. Additionally, BVS stock is highly held by 10 percent owner Juniper Investment Company, LLC and director HAWKINS WILLIAM A among others.

Company executives, directors, and other insiders own 11.56% percent of Bioventus Inc.'s stock. Within the last six months, there have been 4 transaction(s) in which BVS insiders have sold stock, totaling 47.9K shares. Insiders that have sold shares include CLAYPOOLE ROBERT E, SINGLETON MARK LEONARD, and CHURCH KATRINA J.

There have been 2 transaction(s) during the past 6-months in which Bioventus Inc. insiders have bought stock, totalling 105500 shares

Around 14.18M Bioventus Inc. shares are held by insiders, which represents about 11.56% of BVS stock.

BVS , Bartholdson John A. holds the largest portfolio of the company's shares. BVS shares owned by Bartholdson total nearly 6.94 million.

ESSEX WOODLANDS MANAGEMENT, INC. is the largest institutional owner in BVS which holds 13.02 million shares worth $67.71M or 20.79% of the total BVS shares outstanding followed by STATE STREET CORP with ownership of 111.19 thousand shares representing 0.18% of the BVS ownership. JPMORGAN CHASE & CO is the third largest stakeholder with 106.51 thousand shares or 0.17% of the ownership worth more than $553.83K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BVS is concerned, it is a stock which is optionable.

Number of BVS shares short is 1.02M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 65.37M shares of BVS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BVS has 35.56M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BVS is 3.52.